These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3089687)

  • 1. Tissue-plasminogen activator: a new drug in reperfusion therapy (continuing education credit).
    Strauss E; Rudy EB
    Crit Care Nurse; 1986; 6(3):30-5, 38-43. PubMed ID: 3089687
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue-type plasminogen activator: a new fibrinolytic agent.
    Milligan KS
    Heart Lung; 1987 Jan; 16(1):69-74. PubMed ID: 3098703
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction.
    McGahan L
    Issues Emerg Health Technol; 2001 Jan; (13):1-6. PubMed ID: 11902221
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis and activators of plasminogen.
    Sobel BE
    Heart Lung; 1987 Nov; 16(6 Pt 2):775-9. PubMed ID: 3119522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Future developments in thrombolytic therapy].
    Bode C; Runge MS
    Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary thrombolysis: practical considerations.
    Eisenberg PR; Jaffe AS
    Cardiol Clin; 1987 Feb; 5(1):129-41. PubMed ID: 3103918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy in acute myocardial infarction: an overview (continuing education credit).
    Henderson E
    J Emerg Nurs; 1989; 15(2( Pt 2)):145-51. PubMed ID: 2495375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 9. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
    Verstraete M
    Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 11. Formulating appropriate nursing diagnoses for the patient receiving tissue-type plasminogen activator.
    Brooks-Brunn JA
    Heart Lung; 1987 Nov; 16(6 Pt 2):787-91. PubMed ID: 3119523
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic therapy update.
    Sipperly ME
    Crit Care Nurse; 1985; 5(6):30-4. PubMed ID: 3936680
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic therapy in acute myocardial infarction.
    Smucker DR; Burket MW
    Am Fam Physician; 1988 May; 37(5):265-74. PubMed ID: 3129924
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolytic agents in clinical medicine.
    Verstraete M
    Adv Intern Med; 1988; 33():119-41. PubMed ID: 3125722
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From thrombolytic megatrials to clinical policy-making: facing the facts.
    Naylor CD; Armstrong PW
    Can J Cardiol; 1995 Jun; 11(6):472-6. PubMed ID: 7780867
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of platelets and platelet inhibition in acute myocardial infarction.
    Valettas N; Herrmann HC
    Coron Artery Dis; 2003 Aug; 14(5):357-63. PubMed ID: 12878900
    [No Abstract]   [Full Text] [Related]  

  • 19. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial salvage: thrombolytic therapy.
    Sternbach G; Tintinalli JE
    Emerg Med Clin North Am; 1988 May; 6(2):351-9. PubMed ID: 3127194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.